The Patent Finder

Bellicum Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Bellicum Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Bellicum Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 9,434,935Modified Caspase Polypeptides and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 9,932,572Modified Caspase Polypeptides and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 9,944,690Methods for Controlling T Cell Proliferation
In force
 · High confidence
In forceHigh confidence
US 10,525,110Methods for Inducing Partial Apoptosis Using Caspase Polypeptides
In force
 · Low confidence
In forceLow confidence
US 11,839,647Methods for Inducing Partial Apoptosis Using Caspase Polypeptides
In force
 · Medium confidence
In forceMedium confidence
US 9,913,882Methods for Inducing Partial Apoptosis Using Caspase Polypeptides
In force
 · High confidence
In forceHigh confidence
US 10,888,608Costimulation of Chimeric Antigen Receptors by MYD88 and CD40 Polypeptides
In force
 · High confidence
In forceHigh confidence
US 10,918,705Costimulation of Chimeric Antigen Receptors by MYD88 and CD40 Polypeptides
In force
 · High confidence
In forceHigh confidence
US 10,934,346MODIFIED T CELL COMPRISING A POLYNUCLEOTIDE ENCODING AN INDUCIBLE STIMULATING MOLECULE COMPRISING MyD88, CD40 AND FKBP12
In force
 · High confidence
In forceHigh confidence
US 12,410,231Natural Killer Cell Products and Methods
In force
 · High confidence
In forceHigh confidence
10 of 30 records shown.
Pro members see all 30.
Pro members: see all 30 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited